Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Clinical Trial Report
A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,168 | Dovepress* | 6,500+ | 686 | 7,186 | |
| PubMed Central* | 668 | 171 | 839 | ||
| Totals | 7,168 | 857 | 8,025 | ||
| *Since 7 May 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar